These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diffuse thymic hyperplasia following chemotherapy for nodular sclerosing Hodgkin's disease. An immunologic rebound phenomenon? Shin MS; Ho KJ Cancer; 1983 Jan; 51(1):30-3. PubMed ID: 6821803 [TBL] [Abstract][Full Text] [Related]
3. Thymic hyperplasia in a case of Hodgkin's disease. Grissom JR; Durant JR; Whitley RJ; Flint A South Med J; 1983 Sep; 76(9):1189-92. PubMed ID: 6604334 [No Abstract] [Full Text] [Related]
4. [Diffuse thymus hyperplasia following chemotherapy for nodular sclerosing Hodgkin lymphoma]. Hermann R; Greminger P; Dommann-Scherrer C; Krestin GP; Stahel R Schweiz Med Wochenschr; 1994 Sep; 124(38):1666-71. PubMed ID: 7524146 [TBL] [Abstract][Full Text] [Related]
5. [Diffuse hyperplasia of the thymus after chemotherapy for Hodgkin's disease]. Moreira JR; Brito U; Rosado J; Gaspar L; Soromenho F Acta Med Port; 1992 May; 5(5):291-2. PubMed ID: 1502943 [No Abstract] [Full Text] [Related]
6. Myasthenia gravis and thymic Hodgkin's disease associated in one patient with familial lymphoproliferative disorders. Padua L; Palmisani MT; Di Trapani G; Evoli A; Larrocca LM; Tonali P Clin Neuropathol; 1994; 13(5):292-4. PubMed ID: 7805314 [TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma]. Zhen ZJ; Sun XF; Xia Y; Wang ZH; Ling JY Ai Zheng; 2006 Apr; 25(4):471-5. PubMed ID: 16613683 [TBL] [Abstract][Full Text] [Related]
8. Uncommon presentations of Hodgkin's disease. Case 3. Hodgkin's disease: rectal presentation. Simpson L; Taylor S; Piotrowski A J Clin Oncol; 2004 Jan; 22(1):196-8. PubMed ID: 14701784 [No Abstract] [Full Text] [Related]
9. [Radiotherapy in Hodgkin's disease]. Biran S Harefuah; 1972 Dec; 83(12):590-3. PubMed ID: 4659032 [No Abstract] [Full Text] [Related]
11. [Hodgkin's disease: a curable cancer]. Rozencweig M; Kenis Y; Goffin JC; Mendes da Costa P Brux Med; 1975 Sep; 55(9):473-81. PubMed ID: 1231950 [No Abstract] [Full Text] [Related]
12. [Treatment of clinical stages I and II of Hodgkin's disease]. Tubiana M; Mathé G; Hayat M; le Bourgeois JP; Henry-Amar M; Laugier A Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):463-72. PubMed ID: 917835 [No Abstract] [Full Text] [Related]
13. Thymic hyperplasia following successful chemotherapy for Hodgkin's lymphoma: report of a case. Lin TL; Shih LY; Hung YS; Kuo TT Chang Gung Med J; 2009; 32(1):98-103. PubMed ID: 19292945 [TBL] [Abstract][Full Text] [Related]
15. Updated Hodgkin's disease: B. Curability of localized disease. Prognostic influences and radiation therapy according to pattern of disease. Peters MV; Brown TC; Rideout DF JAMA; 1973 Jan; 223(1):53-9. PubMed ID: 4739088 [No Abstract] [Full Text] [Related]
16. [Changes in the spleen structure during treatment of patients with generalized Hodgkin's disease]. Gubareva AV; Markochev AB; Simbirtseva LP; Asaturian MA Eksp Onkol; 1988; 10(5):70-3. PubMed ID: 3208697 [TBL] [Abstract][Full Text] [Related]
17. Balancing efficacy and safety in the treatment of adolescents with Hodgkin's lymphoma. Metzger ML; Hudson MM J Clin Oncol; 2009 Dec; 27(36):6071-3. PubMed ID: 19901130 [No Abstract] [Full Text] [Related]
18. Is the treatment of Hodgkin's disease detrimental to the parathyroid gland? Miltényi Z; Keresztes K; Lakos G; Váróczy L; Miltényi L; Illés A Acta Haematol; 2004; 112(3):148-51. PubMed ID: 15345897 [TBL] [Abstract][Full Text] [Related]
19. [Granulomatous tumors of a pseudo-Hodgkin type of the thymus gland (thymus gland lymphogranulosarcomas)]. Boumghar M Schweiz Med Wochenschr; 1980 Oct; 110(43):1575-83. PubMed ID: 7466334 [TBL] [Abstract][Full Text] [Related]